Factory Supply H-4-ABZ-Glu-OH - 3-Bromo-4-Fluorobenzaldehyde CAS 77771-02-9 High Quality – Ruifu
Factory Supply H-4-ABZ-Glu-OH - 3-Bromo-4-Fluorobenzaldehyde CAS 77771-02-9 High Quality – Ruifu Detail:
Manufacturer with High Purity and Stable Quality
Chemical Name: 3-Bromo-4-Fluorobenzaldehyde
CAS: 77771-02-9
High Quality, Commercialized Production
Chemical Name | 3-Bromo-4-Fluorobenzaldehyde |
CAS Number | 77771-02-9 |
CAT Number | RF-PI320 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C7H4BrFO |
Molecular Weight | 203.01 |
Melting Point | 31.0~33.0℃(lit.) |
Boiling Point | 138.0~139.0℃/2.5 mmHg (lit.) |
Density | 1.6698 |
Refractive Index | 1.574 |
Solubility | Insoluble in Water |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Powder |
Identification IR | Sample Spectrum corresponds to that of reference standard |
Identification HPLC | The retention time of the major peak of the sample solution corresponds to that of the standard solution |
Related Substances | |
20H01 | ≤0.10% |
20H02 | ≤0.10% |
20H04 | ≤0.10% |
20HIb | ≤0.10% |
20H21 | ≤0.10% |
Any Unspecified Impurity | ≤0.10% |
Total Unspecified Impurities | ≤0.30% |
Total Impurities | ≤0.50% |
Residual Solvents | |
N-Heptane | ≤5000ppm |
Ethanol | ≤5000ppm |
Isopropyl Acetate | ≤5000ppm |
Acetonitrile | ≤410ppm |
Methylene Dichloride | ≤600ppm |
Acetone | ≤5000ppm |
Isopropanol | ≤5000ppm |
Water Content (K.F) | ≤0.50% |
Loss on Drying | ≤1.0% |
Residue on Ignition | ≤0.10% |
Optical Rotation | -7.5° to -9.5° (C=0.5, Methanol) |
Heavy Metals | ≤10ppm |
Purity / Analysis Method | ≥99.5% (230nm) |
Assay / Analysis Method | 98.0%~102.0% (HPLC on dried basis) |
Shelf Life | 24 Months |
Test Standard | Enterprise Standard |
Usage | API, Molnupiravir (EIDD-2801) COVID-19 Inhibitor |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19. Molnupiravir is sold under the brand name Lagevrio and generically as emorivir. Molnupiravir has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, Molnupiravir, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus. Molnupiravir was originally developed to treat influenza at Emory University by the university’s drug innovation company, Drug Innovation Ventures at Emory (DRIVE), but was reportedly abandoned for mutagenicity concerns. It was then acquired by Miami-based company Ridgeback Biotherapeutics, which later partnered with Merck & Co. to develop the drug further. Molnupiravir was approved for medical use in the United Kingdom in November 2021.
Product detail pictures:
Related Product Guide:
Reliable quality and good credit standing are our principles, which will help us at a top-ranking position. Adhering to the tenet of "quality first, customer supreme" for Factory Supply H-4-ABZ-Glu-OH - 3-Bromo-4-Fluorobenzaldehyde CAS 77771-02-9 High Quality – Ruifu , The product will supply to all over the world, such as: Swedish, Botswana, America, We strive for excellence, constant improvement and innovation, is committed to make us the "customer trust" and the "first choice of engineering machinery accessories brand" suppliers. Choose us, sharing a win-win situation!
By Jean Ascher from Swaziland - 2018.09.29 17:23
We have been cooperated with this company for many years, the company always ensure timely delivery ,good quality and correct number, we are good partners.
By Lilith from Uzbekistan - 2018.09.12 17:18